Lam Research Co. (NASDAQ:LRCX) Position Boosted by Washington Trust Advisors Inc.

Washington Trust Advisors Inc. lifted its stake in Lam Research Co. (NASDAQ:LRCX) by 25.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 185 shares of the semiconductor company’s stock after purchasing an additional 38 shares during the quarter. Washington Trust Advisors Inc.’s holdings in Lam Research were worth $145,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the stock. Valued Wealth Advisors LLC acquired a new stake in shares of Lam Research during the 4th quarter valued at $30,000. Bollard Group LLC boosted its stake in Lam Research by 60.0% during the 2nd quarter. Bollard Group LLC now owns 40 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 15 shares during the period. Orion Capital Management LLC acquired a new stake in Lam Research in the 3rd quarter valued at approximately $25,000. BluePath Capital Management LLC bought a new position in Lam Research in the 3rd quarter worth approximately $28,000. Finally, Resurgent Financial Advisors LLC acquired a new position in shares of Lam Research during the second quarter worth approximately $29,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Trading Up 0.5 %

NASDAQ:LRCX traded up $4.97 on Thursday, hitting $970.64. 250,205 shares of the stock were exchanged, compared to its average volume of 1,067,183. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.02 and a current ratio of 3.06. The stock has a market capitalization of $127.25 billion, a price-to-earnings ratio of 37.49, a P/E/G ratio of 3.44 and a beta of 1.51. The company’s 50-day moving average price is $903.24 and its 200 day moving average price is $761.16. Lam Research Co. has a 52 week low of $480.45 and a 52 week high of $1,007.39.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.06 by $0.46. The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.71 billion. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. The firm’s revenue was down 28.8% on a year-over-year basis. During the same period last year, the company earned $10.71 EPS. On average, equities research analysts forecast that Lam Research Co. will post 28.88 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 3rd. Investors of record on Wednesday, March 13th will be issued a dividend of $2.00 per share. The ex-dividend date of this dividend is Tuesday, March 12th. This represents a $8.00 dividend on an annualized basis and a dividend yield of 0.82%. Lam Research’s payout ratio is 30.94%.

Insider Transactions at Lam Research

In related news, Director Abhijit Y. Talwalkar sold 882 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $768.75, for a total transaction of $678,037.50. Following the completion of the transaction, the director now owns 11,604 shares in the company, valued at $8,920,575. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CAO Christina Corrreia sold 647 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $768.75, for a total transaction of $497,381.25. Following the sale, the chief accounting officer now owns 5,492 shares in the company, valued at approximately $4,221,975. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Abhijit Y. Talwalkar sold 882 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $768.75, for a total transaction of $678,037.50. Following the completion of the transaction, the director now directly owns 11,604 shares of the company’s stock, valued at $8,920,575. The disclosure for this sale can be found here. Insiders sold 19,895 shares of company stock valued at $15,666,586 in the last ninety days. 0.32% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on LRCX shares. The Goldman Sachs Group boosted their target price on shares of Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a research report on Thursday, January 25th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $900.00 price target on shares of Lam Research in a report on Monday, March 4th. Needham & Company LLC lifted their price objective on Lam Research from $800.00 to $900.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. TD Cowen upped their price objective on Lam Research from $710.00 to $975.00 and gave the company an “outperform” rating in a research note on Thursday, January 25th. Finally, Mizuho raised their target price on Lam Research from $900.00 to $935.00 and gave the stock a “buy” rating in a research report on Thursday, January 25th. Eight equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $811.68.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.